Acyclovir Dosing in End-Stage Renal Disease
For adults with end-stage renal disease on hemodialysis, acyclovir should be dosed at 2.5-5 mg/kg IV every 24 hours, with an additional dose administered after each dialysis session. 1, 2
Standard Renal Dosing (Normal Function)
For patients with normal renal function (CrCl >50 mL/min), standard acyclovir dosing is:
- Oral: 200-800 mg 3-5 times daily
- IV: 5-10 mg/kg every 8 hours (depending on indication)
For herpes simplex encephalitis specifically, the dose is 10 mg/kg IV every 8 hours 1, 2
Hemodialysis Dosing
When creatinine clearance is <10 mL/min or the patient is receiving hemodialysis:
- Oral: 200 mg every 12 hours 3, 1
- IV: 2.5-5 mg/kg every 24 hours 3, 1, 2
- Critical addition: Give a supplemental dose (same as maintenance dose) after each dialysis session 3, 1, 2
The rationale for post-dialysis dosing is that hemodialysis removes approximately 60% of acyclovir from the body over a 4-6 hour dialysis session, with a dialysis clearance of 81-113 mL/min 4, 5. The half-life during dialysis drops from 19.5 hours (in anuric patients) to approximately 5.4-5.7 hours 4, 5.
Critical Dosing Adjustments by Creatinine Clearance
The 2014 IDSA guidelines 1 provide this algorithmic approach:
For IV acyclovir (high-dose for zoster):
- CrCl 25-50 mL/min: 5-10 mg/kg every 12 hours
- CrCl 10-24 mL/min: 5-10 mg/kg every 24 hours
- CrCl <10 mL/min: 2.5-5 mg/kg every 24 hours
- Hemodialysis: 2.5-5 mg/kg every 24 hours, dose post-dialysis
For oral acyclovir:
- CrCl 25-50 mL/min: 200-800 mg 3-5 times daily (no change)
- CrCl 10-24 mL/min: 200-800 mg every 8 hours
- CrCl <10 mL/min: 200-800 mg every 12 hours
- Hemodialysis: Dose after dialysis 1
Neurotoxicity Risk
This dosing precision is critical because acyclovir neurotoxicity is a well-documented complication in ESRD patients, even with "reduced" doses. 6, 7, 8 The terminal half-life increases from 2.5 hours in normal renal function to 19.5 hours in anuria 2, 5. Peak plasma levels are approximately twice as high in anuric patients compared to those with normal renal function 4.
Research demonstrates that a loading dose of 400 mg oral followed by 200 mg twice daily maintains therapeutic levels (6.4 μM) while avoiding neurotoxicity in dialysis patients 6. Using standard doses (800 mg twice daily) in dialysis patients has resulted in acute neurotoxicity requiring extended hemodialysis sessions for treatment 6, 7, 8.
Practical Algorithm
- Determine renal function (calculate CrCl using ideal body weight for obese patients) 2
- Select route (IV preferred for severe infections, encephalitis)
- Adjust dose AND interval based on CrCl using tables above
- For hemodialysis patients: Always give supplemental dose post-dialysis
- Monitor closely for neuropsychiatric symptoms (confusion, hallucinations, tremors) which indicate potential neurotoxicity 8, 9
The FDA label 2 explicitly states that hemodialysis results in a 60% decrease in plasma concentrations over 6 hours, necessitating the additional post-dialysis dose to maintain therapeutic levels.